India Bans Pioglitazone, Analgin Under New Policy Copying Foreign Action
This article was originally published in PharmAsia News
Executive Summary
In a decision affecting several of its drug makers, particularly Zydus Cadila, India's health ministry has issued a ban on pioglitazone for treating diabetes and analgin, a painkiller.